Prognostic significance of recurrent chromosomal aberrations detected by comparative genomic hybridization in sporadic colorectal cancer

被引:66
作者
De Angelis, PM [1 ]
Stokke, T [1 ]
Beigi, M [1 ]
Mjåland, O [1 ]
Clausen, OPF [1 ]
机构
[1] Norwegian Natl Hosp, Inst Pathol, N-0027 Oslo, Norway
关键词
colorectal tumors; comparative genomic hybridization; chromosomal gains/losses; survival;
D O I
10.1007/s003840000275
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Colorectal carcinomas are characterized by frequent recurrent gains and losses of chromosomal material, especially gains of chromosome arms 20q and 13q, and losses of chromosome arms 18q and 4q. These may be important in the development and progression of colorectal carcinomas. Chromosomal aberrations detected by comparative genomic hybridization in 67 sporadic colorectal carcinomas were examined for their possible associations with patient survival. Dukes' stage, tumor DNA ploidy status, and TP53 genotype/phenotype were also examined for the same. Patients with losses of chromosomal arms 1p, 4q, 8p, 14q, or 18q or gain of chromosomal arm 20q had significantly shorter survival times than those without these aberrations (univariate relative risk 3.45, 2.71, 3.32, 3.26, 3.32, 3.91, respectively), as did patients with more than six chromosomal aberrations per tumor than those with fewer than six aberrations (univariate relative risk 3.26, P=0.013). DNA aneuploidy and Dukes' stage C+D resulted in poor patient survival (univariate relative risk 3.58, 3.39, respectively). Dukes' stage C+D, 1p loss and 8p loss emerged as the only independent prognostic parameters (relative risk 3.22, 2.53, 2.45, respectively) when entered into multivariate survival analysis together with other significant parameters from univariate survival analysis. Loss of chromosome arm 1p, 4q, 8p, 14q, or 18q or gain of chromosome arm 20q thus results in shortened survival times in colorectal cancer patients. 1p loss and 8p loss were shown to be independent predictors of poor prognosis.
引用
收藏
页码:38 / 45
页数:8
相关论文
共 48 条
[1]  
Al-Mulla F, 1999, GENE CHROMOSOME CANC, V24, P306, DOI 10.1002/(SICI)1098-2264(199904)24:4<306::AID-GCC3>3.0.CO
[2]  
2-5
[3]  
Arribas R, 1999, LAB INVEST, V79, P111
[4]   OVEREXPRESSION OF P53 AND LONG-TERM SURVIVAL IN COLON-CARCINOMA [J].
AUVINEN, A ;
ISOLA, J ;
VISAKORPI, T ;
KOIVULA, T ;
VIRTANEN, S ;
HAKAMA, M .
BRITISH JOURNAL OF CANCER, 1994, 70 (02) :293-296
[5]   Loss of heterozygosity of 14q32 in colorectal carcinoma [J].
Bando, T ;
Kato, Y ;
Ihara, Y ;
Yamagishi, F ;
Tsukada, K ;
Isobe, M .
CANCER GENETICS AND CYTOGENETICS, 1999, 111 (02) :161-165
[6]   KARYOTYPIC CHARACTERIZATION OF COLORECTAL ADENOCARCINOMAS [J].
BARDI, G ;
SUKHIKH, T ;
PANDIS, N ;
FENGER, C ;
KRONBORG, O ;
HEIM, S .
GENES CHROMOSOMES & CANCER, 1995, 12 (02) :97-109
[7]   Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer [J].
Carethers, JM ;
Hawn, MT ;
Greenson, JK ;
Hitchcock, CL ;
Boland, CR .
GASTROENTEROLOGY, 1998, 114 (06) :1188-1195
[8]  
CUNNINGHAM C, 1993, ONCOGENE, V8, P1391
[9]  
De Angelis PM, 1998, J CLIN PATHOL-MOL PA, V51, P254
[10]  
De Angelis PM, 1999, BRIT J CANCER, V80, P526